Guidant Japan Establishes New Facility for Physician Education; Guidant's Institute for Therapy Advancement - Japan Continues Leadership in Medical Education.Business Editors/Health/Medical Writers INDIANAPOLIS & TOKYO--(BUSINESS WIRE)--May 30, 2003 Guidant Corporation (NYSE NYSE See: New York Stock Exchange :GDT GDT Global Descriptor Table GDT Geographic Data Technology Inc. GDT Gas Discharge Tube (energy, electrotechinical and electronics) GDT Getting Things Done GDT Geometric Dimensioning & Tolerancing GDT Ground Data Terminal ), a world leader in the treatment of cardiac and vascular disease, today announced the establishment of the Guidant Institute for Therapy Advancement - Japan, an innovative facility in Tokyo that will provide physicians with unique opportunities to enhance their knowledge and expertise on the most current cardiovascular therapies and techniques. The Institute is part of Guidant's ongoing commitment to providing physicians with the latest training and technology to advance the treatment of cardiovascular disease Cardiovascular disease Disease that affects the heart and blood vessels. Mentioned in: Lipoproteins Test cardiovascular disease . Members of Guidant's Management Committee and the Japanese Advisory Board, which is composed of senior Japanese advisors drawn from government and business, gathered in Tokyo today to celebrate the opening of the Institute. The group addressed several members of the Japanese media The communications media of Japan include numerous television and radio networks as well as newspapers and magazines. For the most part, television networks were established based on the capital contribution from existing radio networks at that time. on site to tour the Institute. The new facility will begin offering programs in the third quarter of 2003. "Our investment in the new Guidant Institute for Therapy Advancement - Japan reflects Guidant's commitment to Japan, its healthcare system and its physicians," said Ron Lattanze, president, Japan, Guidant Corporation. "We are confident that this Institute will fill an important need in Japan to provide cardiac specialists with more access to, and experience with, rapidly changing cardiovascular therapies and techniques." The scientific integrity of programs at the Institute will be guaranteed by independent course directors, who are widely respected physicians and who have extensive daily clinical practice. The Guidant Institute for Therapy Advancement - Japan is modeled on the successful Guidant Institute for Therapy Advancement - Europe, which facilitates educational courses on cardiac and vascular therapies for approximately 2,000 clinicians each year. The European facility recently received Continuous Medical Education (CME CME See: Chicago Mercantile Exchange CME See Chicago Mercantile Exchange (CME). ) accreditation accreditation, n a process of formal recognition of a school or institution attesting to the required ability and performance in an area of education, training, or practice. from the European Board of Accreditation in Cardiology cardiology Medical specialty dealing with heart diseases and disorders. It began with the 1749 publication by Jean Baptiste de Sénac of contemporary knowledge of the heart. Diagnostic methods improved in the 19th century, and in 1905 the electrocardiograph was invented. . Guidant Corporation pioneers lifesaving technology, giving an opportunity for better life today to millions of cardiac and vascular patients worldwide. The company, driven by a strong entrepreneurial culture of 11,000 employees, develops, manufactures and markets a broad array of products and services that enable less invasive care for some of life's most threatening medical conditions See carpal tunnel syndrome, computer vision syndrome, dry eyes and deep vein thrombosis. . For more information visit www.guidant.com. NOTE TO MEDIA: For more information about Guidant, including its products and services, please visit the company's newsroom at www.guidant.com/newsroom. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion